Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.174
-0.004 (-2.47%)
At close: Mar 6, 2026
-56.38%
Market Cap 11.17M
Revenue (ttm) 47.00K
Net Income (ttm) -6.93M
Shares Out 64.36M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 323,657
Average Volume 169,618
Open 0.175
Previous Close 0.178
Day's Range 0.165 - 0.175
52-Week Range 0.150 - 0.700
Beta -0.27
RSI 37.95
Earnings Date Feb 20, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.